LGC LGC
  • About us
    • About LGC
    • Our history
    • Leadership team
    • Our locations
    • ESG
    • Reports & documents
  • What we do
    • Diagnostics and Genomics
      • SeraCare Clinical Diagnostics
      • Biosearch Technologies Oligo Synthesis
      • Lucigen Reagent Components
      • Rapid Genomics Genotyping Solutions
    • Assurance
      • Reference standards, research chemicals & proficiency testing
      • Supply chain assurance
      • National Laboratories & Science
    • Nucleic Acid Therapeutics
      • Axolabs
  • Careers
    • Our people
    • Careers at LGC
  • News
  • Contact us
Buy from us

Follow us on social media

News and updates from across the LGC Group

To contact the press office please email or call +44 7408 850 514

NML collaborate to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing

25 January 2024

The National Measurement Laboratory and UK NEQAS for Leucocyte Immunophenotyping announce collaboration to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing.

Read More

LGC Genomics opens new state-of-the-art laboratory facility in North London

16 January 2024

New laboratory officially opened by David Willetts, UK Minister for Universities and Science.

Read More

LGC introduces sbeadex™ Lightning, a pioneering nucleic acid extraction process

15 January 2024

LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes

Read More

LGC mid-year Update: 1 April – 30 September 2023

15 December 2023

LGC announces half year trading results

Read More

LGC acquires PolyDesign

14 November 2023

LGC acquires PolyDesign, a provider of innovative oligo solid support products for life sciences customers.  

Read More

LGC supports the UK leadership for accurate diagnostics in future pandemics

02 November 2023

National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.

Read More

LGC acquires Virusys Corporation.

09 October 2023

LGC Clinical Diagnostics, a business unit of LGC, today announced the acquisition of Virusys Corporation, a developer and manufacturer of monoclonal antibodies and viral antigens.

Read More

LGC Group appoints David King as Non-Executive Director and Chairman

28 September 2023

LGC announced today the appointment of David P. King as Non-Executive Chairman of its Board of Directors.

Read More

Review of methods and challenges associated with detection of precision bred products

18 September 2023

The UK National Reference Laboratory for GMOs based at LGC has reviewed the current state-of-the-art methods for the potential detection of Precision Bred Organisms (PBOs) in food and feed supply chains and to provide recommendations towards developing a framework for the traceability of PBOs.

Read More

LGC acquires Kova International, Inc., including Biochemical Diagnostics, Inc., strengthening its portfolio of Quality Measurement Tools

24 July 2023

Today, LGC Clinical Diagnostics, a business unit of LGC, announced the acquisition of Kova International, Inc. (Kova), a leading developer and manufacturer of in vitro urinalysis and toxicology quality control products for clinical laboratories

Read More

DNA identifies five more Australian World War I soldiers

25 April 2023

Five more soldiers who fell at the Battle of Fromelles more than 100 years ago have been identified using DNA analysis performed by LGC.

Read More

National Measurement Laboratory at LGC launches cell metrology lab in Leeds

04 April 2023

The first step in a partnership between the University of Leeds and the NML, the laboratory was launched on Friday, 31 March 2023 at a special event hosted Nexus, which features talks from Professors Julian Braybrook and Nick Plant, as well as a visit from the Mayor of West Yorkshire Tracy Brabin.

Read More
  • PREV
  • 1
  • 2
  • 3
  • 4
  • …
  • 20
  • NEXT
LGC LGC

Contact us

Follow us on social media

About us
  • About LGC
  • Our locations
  • Leadership team
  • ESG
  • Reports & documents
What we do
  • Clinical diagnostics
  • Oligo synthesis
  • Reagent components
  • Genotyping solutions
  • Reference standards, research chemicals & proficiency testing
  • Nucleic acid therapeutic services
  • Supply chain assurance
  • National Laboratories & Science
Policies
  • Terms and conditions
  • Website Privacy Notice
  • Cookie policy
  • Privacy Notices
  • LGC modern slavery statement
  • Manage cookie settings
Careers
  • Careers at LGC
  • Our people
  • News
  • Contact us

© LGC Limited, 2026.
All rights reserved. All trademarks acknowledged.

LGC Limited Registered in England No. 2991879. VAT No. 674 056 721
Registered office: LGC, The Priestley Building, 10 Priestley Road, Guildford, GU2 7XY, UK

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}